CVS, Amniocentesis, Nuchal Translucency

CVS, Amniocentesis, Nuchal Translucency


You're mentioning three different types of prenatal tests—CVS (Chorionic Villus Sampling), Amniocentesis, and Nuchal Translucency (NT) screening—that are used to check for genetic or chromosomal conditions in a developing fetus. Here's a quick breakdown of each:

CVS (Chorionic Villus Sampling)

When it's done : Typically between 10–13 weeks of pregnancy.

How it's done : A sample of chorionic villi (tiny finger-like projections from the placenta) is taken through the cervix (transcervical) or abdomen (transabdominal).

What it tests for : Chromosomal abnormalities (like Down syndrome, trisomy 13, trisomy 18), and some genetic disorders (like cystic fibrosis, Tay-Sachs).

Pros : Done early; results are typically available faster than amniocentesis.

Risks : Slight risk of miscarriage (~0.22% according to recent studies).

Amniocentesis

When it's done : Usually between 15–20 weeks of pregnancy.

How it's done : A needle is inserted through the abdomen to take a small sample of amniotic fluid.

What it tests for : Chromosomal abnormalities, neural tube defects (like spina bifida), and some genetic disorders.

Pros : Very accurate; can detect a broader range of issues than CVS (including open neural tube defects).

Risks : Slight risk of miscarriage (~0.1–0.3%).

Nuchal Translucency (NT) Screening

When it's done : Between 11–14 weeks of pregnancy.

How it's done : An ultrasound measures the clear (translucent) space at the back of the baby's neck.

What it screens for : Risk of chromosomal abnormalities like Down syndrome (trisomy 21), trisomy 18, and heart problems.

Pros : Non-invasive; part of the first-trimester screening when combined with blood tests.

Limitations : It's a screening, not a diagnostic test—so it only gives a risk estimate.

MAke an appointment